The FTIR has a detection limit of approximately 5%. Substances below this level may not appear in results — even if they are toxic or affect the potency of your sample.
When possible, we may provide a percentage estimate based on what the FTIR detects. These numbers are generated by software and reflect only the visible components — not the full composition of the sample. The FTIR cannot isolate individual substances in complex mixtures, so any percentage estimates are approximate. They may not reflect actual potency, and similar-looking samples can yield different results – therefore we do not provide purity testing. Any percentages we offer are estimates based on the visible ingredients identified through FTIR spectroscopy. Since this method does not account for the entire sample, undetected ingredients below the detection threshold may influence the composition. The percentages are intended only as a general indication of how the identified ingredients are distributed within the sample. Due to this, any percentages provided cannot be used to calculate milligram quantities within a sample. Our results should not be used to determine exact dosages.
Additionally, a sample may not reflect the full composition of a drug. For example, testing part of a pill may not represent the rest. Cross-contamination between samples stored together can also affect results.
When we detect only one substance, we don’t provide a percentage because other ingredients might still be present below the 5% detection limit.
Treat any percentage result as a rough guideline, not a precise measurement.
Tests highlighted in red indicate particularly dangerous or unexpected results. Flagged samples can alslo be viewed on our Alerts page.
We also use test strips to detect the presence of fentanyl, benzodiazapenes, and lysergamide (LSD).
The results provided are strictly for personal use and educational purposes. They must not be published, distributed, or shared publicly in any form. Unauthorized sharing, reproduction, or publication of these results is strictly prohibited and may result in disciplinary action.
If you find our results shared elsewhere, please be aware that such use is unauthorized and we do not condone it. Images or representations of our results can be easily replicated or altered online, potentially containing misleading or false information. We strongly recommend testing your own samples to ensure accuracy and reliability.
Category: Psychedelic White Crystal Code: Underhill R
Ketamine
Ketamine
Fentanyl: Negative
Vancouver, BC
09/10/2025
Category: Depressant White Granules
Alprazolam
Microcrystalline Cellulose
Uncertain Oil
Uncertain Match
Fentanyl: Negative Benzodiazepine: Positive
Vancouver, BC
09/10/2025
Category: Psychedelic Colourless Crystal Code: Underhill S
Ketamine
Ketamine
Fentanyl: Negative
Vancouver, BC
09/10/2025
Category: Stimulant White Powder
Cocaine
Cocaine
Glutamine
Fentanyl: Negative
Vancouver, BC
09/10/2025
Category: Opioid Dark Brown Paste
Opium
Caffeine
Opium
Uncertain Carbohydrate
Uncertain Oil
Fentanyl: Negative Benzodiazepine: Negative
Vancouver, BC
09/10/2025
Category: Unknown White Crystal
Unknown
Medetomidine
Fentanyl: Negative Benzodiazepine: Negative
Medetomidine is an anesthetic drug approved only for use on animals and is considered to be more potent than xylazine. The risk of extreme drowsiness and sedation is increased when medetomidine is used in combination with high-potency opioids, benzodiazepine-related drugs, and xylazine. Other harmful and unexpected effects, such as cardiac and circulatory system depression and serious respiratory depression, can be life-threatening. Naloxone is not effective in reversing medetomidine.
The majority of this sample appeared to be despropionyl para-fluorofentanyl, with a small uncertain match. This sample had a high moisture content which can make identifying substances difficult as the water content can skew what we see by FTIR.
Vancouver, BC
09/10/2025
Category: Unknown White Crystal
Unknown
Medetomidine
Fentanyl: Negative Benzodiazepine: Negative
Medetomidine is an anesthetic drug approved only for use on animals and is considered to be more potent than xylazine. The risk of extreme drowsiness and sedation is increased when medetomidine is used in combination with high-potency opioids, benzodiazepine-related drugs, and xylazine. Other harmful and unexpected effects, such as cardiac and circulatory system depression and serious respiratory depression, can be life-threatening. Naloxone is not effective in reversing medetomidine.
Vancouver, BC
09/10/2025
Category: Unknown Light Yellow Powder
Unknown
No Library Match
Fentanyl: Negative Benzodiazepine: Negative
No library match, sample shared similarities with flualprazolam, but too small to identify